Threshold Pharmaceuticals (THLD US)

Molecular Templates, Inc. operates as a biopharmaceutical company. The Company focuses on discovery, development, and commercialization of immunotoxins for treatment of cancers and other serious diseases. Molecular Templates also develops novel therapeutic compounds for cancer. Molecular Templates serves patients in the United States.